FDA NDC Directory · JSON-LD · Markdown

Siliq

NDC 0187-0004 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameBrodalumab
Labeler / ManufacturerBausch Health US LLC
Marketing categoryBiologic License Application · App BLA761032
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsBRODALUMAB (210 mg/1)
Marketing started20170215
Package count1

External sources

Source: openFDA. Public-domain (CC0).